Ernexa Therapeutics Inc.: Form SC 13D, filed Feb 5, 2018
Filed with the SEC on Feb 5, 2018 and accepted by EDGAR at Feb 5, 2018, 08:00 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001477932-18-000647. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.